Glaukos Corporation Common Stock (NY:GKOS)

164.84 -0.76 (-0.46%)

Official Closing Price Updated: 7:00 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Glaukos Corporation Common Stock

< Previous 1 2 3 4 5 6 7 Next >

Glaukos (NYSE:GKOS): High Growth Momentum Meets a Breakout Setup ↗

Today 5:30 EDT

Via Chartmill

If You Invested $1000 In Glaukos Stock 10 Years Ago, You Would Have This Much Today ↗

September 10, 2026

Glaukos (NYSE:GKOS) has outperformed the market over the past 10 years by 3.9% on an annualized basis producing an average annual return of 17.45%. Currently, Glaukos has a market capitalization of...

Via Benzinga

Glaukos (NYSE:GKOS) Passes Minervini Trend Template and High-Growth Momentum Screen ↗

September 01, 2026

Via Chartmill

Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today ↗

August 25, 2026

Glaukos (NYSE:GKOS) has outperformed the market over the past 5 years by 15.09% on an annualized basis producing an average annual return of 26.17%. Currently, Glaukos has a market capitalization of...

Via Benzinga

Glaukos (GKOS) Q2 2026 Earnings Call Transcript ↗

August 07, 2026

iDose TR drove $74M in Q2 revenue as Glaukos raised full-year guidance.

Via The Motley Fool

Topics Earnings

GKOS (Glaukos Corp) Shows Strong Trend Template Compliance and High Growth Momentum on ChartMill ↗

June 20, 2026

Via Chartmill

Glaukos Corp (NYSE:GKOS) Shares Surge on Record Sales and Raised Guidance After Q1 Beat ↗

April 29, 2026

Via Chartmill

Glaukos Corp (NYSE:GKOS) Shows High-Growth Momentum and Fits Key Trend Template Rules ↗

April 03, 2026

Via Chartmill

Glaukos Corp (NYSE:GKOS) Reports Record 2025 Sales but Shares Dip on Wider Loss, Conservative Outlook ↗

February 17, 2026

Via Chartmill

Glaukos Q2 Earnings Call Highlights ↗

July 30, 2026

Glaukos (NYSE:GKOS) reported record second-quarter 2026 consolidated net sales of $185.6 million, up 50% from the prior-year period on a reported basis and 49% on a constant-currency basis, as growth...

Via MarketBeat

Topics Earnings

Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? ↗

July 14, 2026

Disposition represented 19% of insider's equity holdings under pre-established Rule 10b5-1 trading plan. Thurman retains 43,681 shares worth approximately $6.77 million.

Via The Motley Fool

Topics Regulatory Compliance

Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? ↗

July 08, 2026

Abbott trades at a fraction of Glaukos' valuation, but one company burns cash while the other generates billions.

Via The Motley Fool

Glaukos (GKOS) Q1 2026 Earnings Transcript ↗

April 29, 2026

Glaukos (GKOS) Q1 2026 Earnings Transcript

Via The Motley Fool

Xenon Stock at $42: What to Know of a $75 Million Trim Ahead of March Phase 3 Data ↗

February 19, 2026

This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and related conditions.

Via The Motley Fool

Topics Regulatory Compliance

Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead ↗

February 19, 2026

Focused on retinal disease therapies, Kodiak Sciences leads with clinical-stage candidates targeting major unmet needs in ophthalmology.

Via The Motley Fool

Topics Regulatory Compliance

This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗

February 19, 2026

This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline.

Via The Motley Fool

CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale ↗

February 19, 2026

This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients with limited treatment options.

Via The Motley Fool

Topics Regulatory Compliance

BrightSpring Stock Up 86% as Braidwell Takes $45 Million Stake in Healthcare Services Provider ↗

February 19, 2026

BrightSpring Health Services delivers integrated pharmacy and clinical care to Medicare, Medicaid, and insured patients nationwide.

Via The Motley Fool

Topics Regulatory Compliance

Glaukos (GKOS) Q4 2025 Earnings Call Transcript ↗

February 17, 2026

Glaukos (GKOS) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Director Sells GKOS 15,000 Shares for $1.9 Million ↗

January 31, 2026

This ophthalmic device maker, focused on glaucoma solutions, reported a notable insider sale after a challenging year for its stock.

Via The Motley Fool

Topics Regulatory Compliance

These stocks are moving in today's after hours session ↗

January 13, 2026

Via Chartmill

Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off ↗

November 06, 2025

Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off

Via The Motley Fool

Topics Regulatory Compliance

Why Glaukos Stock Zoomed Almost 14% Higher on Thursday ↗

October 30, 2025

The company's recent past featured robust growth, and it anticipates continued rises into the near future.

Via The Motley Fool

Glaukos (GKOS) Q3 2025 Earnings Call Transcript ↗

October 30, 2025

Glaukos (GKOS) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Cardinal Health Posts Upbeat Q1 Results, Joins Guardant Health, Glaukos, C.H. Robinson And Other Big Stocks Moving Higher On Thursday ↗

October 30, 2025

Via Benzinga

Get insights into the top gainers and losers of Thursday's pre-market session. ↗

October 30, 2025

The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 30, 2025

Via Benzinga

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 30, 2025

Via Benzinga

Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

October 30, 2025

Via Benzinga

Why Glaukos Stock Jumped Over 20% After-Hours Today ↗

October 29, 2025

Glaukos shares surged 21% in after-hours trading after the company posted record third-quarter revenue and raised its full-year guidance.

Via Stocktwits

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.